Boston - May 17, 2007 -- A new article published in American Journal of Transplantation examines the dilemmas faced in trying to change kidney transplant policy; addressing the need to balance the benefits of immediate transplants with those to be had from waiting for a more suitable match. The article highlights some of the important points to be considered in any new policy-making, and suggests a new method for allocation, whereby the patients are involved in the decision process.
The majority of deceased-donor kidneys are allocated to patients with end-stage renal disease on a "first-come, first-serve" basis, rather than through careful matching, despite the fact that there is little risk of immediate death from renal ailments. As a result, donated kidneys in excellent condition may be given to patients who are almost certain to die long before the replacement organ wears out, while patients with longer life expectancies may be given organs with a high chance of graft failure, making second or even third transplants necessary later in life.
Recent attention has been focused on designing new methods of prioritization, one that allocates kidneys based on matches with the most favorable risk factors for long-term graft survival. Patients would be ranked based on the expected gain in years-of-life compared to continuing dialysis. However, such a system comes with a number of significant trade-offs, with some ethnic and age groups being more likely to benefit from transplants, and therefore ranking higher than others. The challenge for policy makers is to create a ranking system that takes into account those who do not meet maximum benefit requirements.
In this editorial, Richard B. Freeman, Jr., M.D. presents a solution suggesting that patients themselves decide what level of graft failure risk he or she deems acceptable. Recipients would only be offered kidneys that meet their own standards, rather than being directed by arbitrary allocation policies. Freeman claims that such a system "would have many benefits, including better educating patients so that they could make informed decisions, allowing patients to personally decide where the trade-off between the qualitative and quantitative benefit of a transplant lies, as well as speeding up the organ placement program." An approach of this sort would not prevent low risk grafts from being given to patients with short life expectancies, or vice-versa, but it would ensure that the decision rests with the patient, in contrast to a system where quantitative benefit would always take priority with no patient or care giver input.
The research and viewpoints expressed in the article are those of the author and do not reflect the opinions of the journal or the affiliated societies.
This study is published in the May issue of American Journal of Transplantation. Media wishing to receive a PDF of this article may contact email@example.com.
Richard B. Freeman, Jr., M.D. is a Professor of Surgery at Tufts University School of Medicine. He is also an Associate Editor for the American Journal of Transplantation, however the opinions expressed in his article in no way reflect the views of the journal. He can be reached for questions at firstname.lastname@example.org.
The aim of the American Journal of Transplantation is the rapid publication of new high quality data in organ and tissue transplantation and the related sciences. Its scope includes organ and tissue donation and preservation; tissue injury, repair, inflammation, and aging; immune recognition, regulation, effector mechanisms, and opportunities for induction of tolerance; histocompatibility; drugs and pharmacology relevant to transplantation; graft survival and prevention of graft dysfunction and failure; clinical trials and population analyses; transplant complications; xenotransplantation; and ethical and societal issues. The sciences include relevant aspects of cell biology, medicine, surgery, pediatrics, and infectious diseases. The journal includes thoracic transplantation (heart, lung), abdominal transplantation (kidney, liver, pancreas, islets), transplantation of tissues and related topics. For more information, please visit www.blackwell-synergy.com/loi/ajt.
Blackwell Publishing is the world's leading society publisher, partnering with 665 medical, academic, and professional societies. Blackwell publishes over 800 journals and has over 6,000 books in print. The company employs over 1,000 staff members in offices in the US, UK, Australia, China, Singapore, Denmark, Germany, and Japan and officially merged with John Wiley & Sons, Inc.'s Scientific, Technical, and Medical business in February 2007. Blackwell's mission as an expert publisher is to create long-term partnerships with our clients that enhance learning, disseminate research, and improve the quality of professional practice. For more information on Blackwell Publishing, please visit www.blackwellpublishing.com or www.blackwell-synergy.com.